» Articles » PMID: 36271889

C3-dependent Effector Functions of Complement

Overview
Journal Immunol Rev
Date 2022 Oct 22
PMID 36271889
Authors
Affiliations
Soon will be listed here.
Abstract

C3 is the central effector molecule of the complement system, mediating its multiple functions through different binding sites and their corresponding receptors. We will introduce the C3 forms (native C3, C3 [H O], and intracellular C3), the C3 fragments C3a, C3b, iC3b, and C3dg/C3d, and the C3 expression sites. To highlight the important role that C3 plays in human biological processes, we will give an overview of the diseases linked to C3 deficiency and to uncontrolled C3 activation. Next, we will present a structural description of C3 activation and of the C3 fragments generated by complement regulation. We will proceed by describing the C3a interaction with the anaphylatoxin receptor, followed by the interactions of opsonins (C3b, iC3b, and C3dg/C3d) with complement receptors, divided into two groups: receptors bearing complement regulatory functions and the effector receptors without complement regulatory activity. We outline the molecular architecture of the receptors, their binding sites on the C3 activation fragments, the cells expressing them, the diversity of their functions, and recent advances. With this review, we aim to give an up-to-date analysis of the processes triggered by C3 activation fragments on different cell types in health and disease contexts.

Citing Articles

Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy.

Li Z, Sun Z, Tang S, Zhao M, Chen M, Chang D Cells. 2025; 14(5).

PMID: 40072066 PMC: 11898422. DOI: 10.3390/cells14050337.


Transcriptome analysis of 3D4/21 cells expressing CSFV NS4B.

Dong W, Lv H, Song Y, Lv Y, Xu X, Jing H Front Microbiol. 2025; 16:1510058.

PMID: 39967738 PMC: 11833225. DOI: 10.3389/fmicb.2025.1510058.


Investigating the impact of Premolis semirufa caterpillar bristle toxins on human chondrocyte activation and inflammation.

de Lima C, Pohl P, Villas-Boas I, Pidde G, Tambourgi D PLoS Negl Trop Dis. 2025; 19(2):e0012816.

PMID: 39928679 PMC: 11809898. DOI: 10.1371/journal.pntd.0012816.


C3AR1 as a target for preeclampsia: from bioinformatics and network pharmacology to experimental validation.

Hu Y, Li S, Hong Y, Peng D BMC Pregnancy Childbirth. 2025; 25(1):94.

PMID: 39885406 PMC: 11780793. DOI: 10.1186/s12884-025-07221-y.


Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1-5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy.

Sato S, Miwa T, Gullipalli D, Golla M, Mohammadyari E, Zhou L Immunohorizons. 2025; 9(3).

PMID: 39865974 PMC: 11841979. DOI: 10.1093/immhor/vlae006.


References
1.
Magrini E, Minute L, Dambra M, Garlanda C . Complement activation in cancer: Effects on tumor-associated myeloid cells and immunosuppression. Semin Immunol. 2022; 60:101642. DOI: 10.1016/j.smim.2022.101642. View

2.
Birmingham D, Hebert L . CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev. 2001; 180:100-11. DOI: 10.1034/j.1600-065x.2001.1800109.x. View

3.
Flierl M, Rittirsch D, Nadeau B, Day D, Zetoune F, Sarma J . Functions of the complement components C3 and C5 during sepsis. FASEB J. 2008; 22(10):3483-90. PMC: 2537435. DOI: 10.1096/fj.08-110595. View

4.
Wilson H, Medjeral-Thomas N, Gilmore A, Trivedi P, Seyb K, Farzaneh-Far R . Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. Kidney Int. 2019; 95(3):655-665. PMC: 6389546. DOI: 10.1016/j.kint.2018.09.027. View

5.
Sim R, Malhotra V, Day A, Erdei A . Structure and specificity of complement receptors. Immunol Lett. 1987; 14(3):183-90. DOI: 10.1016/0165-2478(87)90099-x. View